ADC Linker

Fmoc-3VVD-OH is a cleavable linker employed in the synthesis of antibody-drug conjugates (ADCs). This compound facilitates the stable attachment of cytotoxic agents to antibodies, enabling targeted delivery to cancer cells. Its hydrolyzable nature allows for efficient release of the drug in the desired cellular environment, making it a valuable tool in cancer research and therapeutic development.

Gly-Gly-Gly-PEG4-DBCO is a polyethylene glycol (PEG) linker designed for use in antibody-drug conjugates (ADCs). Featuring a dibenzocyclooctyne (DBCO) functional group, this compound facilitates strain-promoted alkyne-azide cycloaddition (SPAAC) reactions with azide-bearing compounds. Its high stability and efficiency make it an essential tool in the development of targeted therapeutics for improved delivery of cytotoxic drugs.

Fmoc-8-amino-3,6-dioxaoctanoic acid is a cleavable linker primarily utilized in the development of antibody-drug conjugates (ADCs). Its PEG-based structure also allows for incorporation in the synthesis of PROTACs (proteolysis-targeting chimeras), facilitating targeted degradation of specific proteins. This reagent provides a functional handle for the attachment of theranostic payloads, enhancing the efficacy and specificity of therapeutic agents in chemical biology research.

Azidoacetic Acid is a versatile click chemistry reagent characterized by its azide group functionality. It serves as a valuable tool for the synthesis of protein-targeting chimeras, such as PROTACs. Azidoacetic Acid can participate in copper-catalyzed azide-alkyne cycloaddition (CuAAc) with alkyne-containing compounds, as well as ring strain-promoted alkyne-azide cycloaddition (SPAAC) with DBCO or BCN moieties, enabling the rapid assembly of bioconjugates and labeled biomolecules for various research applications.

Kdo Azide is a click chemistry reagent that features an azide functional group, allowing it to engage in copper-catalyzed azide-alkyne cycloaddition (CuAAc) reactions with alkynyl compounds. Additionally, Kdo Azide can participate in strain-promoted alkyne-azide cycloaddition (SPAAC) reactions in the presence of DBCO or BCN moieties. This reagent is valuable for metabolic labeling applications and various bioconjugation strategies in chemical biology research.

β-D-glucuronide-pNP-carbonate is a cleavable linker specifically designed for use in antibody-drug conjugates (ADCs). It facilitates the release of cytotoxic drugs in targeted therapeutic applications, thereby enhancing the efficacy of treatment while minimizing off-target effects. This compound is valuable for researchers focusing on the development of ADCs aimed at improving precision in cancer therapies and other diseases.

Fmoc-Gly-NH-CH2-acetyloxy is a cleavable linker specifically designed for the synthesis of antibody-drug conjugates (ADCs). This compound facilitates the stable attachment of cytotoxic drugs to antibodies while allowing for selective release in target cells. Its application is critical in developing advanced therapeutics that improve the efficacy and safety of cancer treatments through targeted drug delivery.

Maleimide is a versatile compound primarily utilized as an ADC linker in cancer research. It is instrumental in the development of antibody-drug conjugates, facilitating targeted delivery of cytotoxic agents to cancer cells. Additionally, Maleimide can be employed in the synthesis of fluorogenic probes, enabling the specific detection and quantification of thiol-containing analytes in various biological samples.

Bromo-PEG2-C2-azide is a versatile PROTAC linker featuring a bromo group and an azide moiety, designed for the synthesis of antibody-drug conjugates (ADCs) and PROTACs. This compound functions effectively in click chemistry through copper-catalyzed azide-alkyne cycloaddition (CuAAc) reactions with alkyne-containing molecules. Additionally, Bromo-PEG2-C2-azide can participate in strain-promoted alkyne-azide cycloaddition (SPAAC) with DBCO or BCN groups, making it a valuable tool for targeted protein degradation and bioconjugation strategies in chemical biology research.

Mal-PEG2-NHS ester is a non-cleavable antibody-drug conjugate (ADC) linker that features a maleimide group, a two-unit polyethylene glycol (PEG) spacer, and an N-hydroxysuccinimide (NHS) ester. This compound is essential for the efficient conjugation of cytotoxic agents to antibodies, facilitating targeted delivery in cancer therapy. Mal-PEG2-NHS ester enhances the stability and solubility of ADCs, making it suitable for research applications in drug development and discovery.

DBCO-Maleimide is a non-cleavable linker specifically designed for the synthesis of antibody-drug conjugates (ADCs). As a click chemistry reagent, it features a DBCO group that facilitates strain-promoted alkyne-azide cycloaddition (SPAAC) with azide-containing molecules. This property enables seamless conjugation and enhances the therapeutic efficacy of ADCs, making DBCO-Maleimide an essential tool in bioconjugation and targeted drug delivery research.

Boc-NH-PEG4-CH2CH2NH2 is a cleavable five-unit polyethylene glycol (PEG) linker designed for use in the synthesis of antibody-drug conjugates (ADCs). This linker facilitates the conjugation of therapeutic agents to antibodies, enhancing target specificity and therapeutic efficacy. Additionally, Boc-NH-PEG4-CH2CH2NH2 serves as a PEG-based linker in the development of PROTACs, contributing to the targeted degradation of proteins in various research applications.

Azido-PEG4-C2-acid is a PEG-based linker designed for use in PROTAC (Proteolysis Targeting Chimeras) applications. It serves as a non-cleavable linker in the synthesis of antibody-drug conjugates (ADCs) and is integral to the development of compounds such as vRucaparib-TP4. This compound features an azide group that enables the copper-catalyzed azide-alkyne cycloaddition reaction (CuAAc) with alkyne-containing molecules, and it also facilitates strain-promoted alkyne-azide cycloaddition (SPAAC) reactions with DBCO or BCN groups, making it a versatile reagent for chemical biology research.

Fmoc-Gly-Gly-Phe-OH is a cleavable linker designed for use in the synthesis of antibody-drug conjugates (ADCs). This compound facilitates the selective release of therapeutic agents in targeted cancer treatment, enhancing the efficacy of the conjugated drug while minimizing systemic exposure. Its utility in ADC formulation makes it a valuable tool for researchers developing innovative cancer therapeutics.

MAC glucuronide linker-2 is a cleavable linker designed for use in the synthesis of antibody-drug conjugates (ADCs). This linker facilitates the targeted delivery of cytotoxic agents to tumor cells, allowing for enhanced efficacy while minimizing off-target effects. It is particularly valuable in research applications focused on ADC development and optimization, contributing to advancements in targeted cancer therapies.

Azido-PEG8-NHS ester is a cleavable 8-unit polyethylene glycol (PEG) linker designed for use in antibody-drug conjugates (ADCs) and proteolysis-targeting chimeras (PROTACs). This compound features an azide functional group that enables it to participate in click chemistry, specifically copper-catalyzed azide-alkyne cycloaddition (CuAAC) and strain-promoted alkyne-azide cycloaddition (SPAAC) with alkyne-containing molecules. Its unique properties make it valuable for the efficient synthesis of ADCs and the development of novel PROTACs.

N3-PEG2-C2-NHS ester is a non-cleavable 2-unit PEG linker designed for the synthesis of antibody-drug conjugates (ADCs). Featuring an azide functional group, it serves as a click chemistry reagent capable of facilitating copper-catalyzed azide-alkyne cycloaddition (CuAAc) with alkyne-containing molecules. Additionally, N3-PEG2-C2-NHS ester participates in strain-promoted alkyne-azide cycloaddition (SPAAC) reactions with DBCO or BCN groups, making it a versatile tool for conjugation applications in bioconjugate chemistry.

N3-C5-NHS ester is a noncleavable ADC linker designed for the synthesis of antibody-drug conjugates (ADCs). It features an azide group that facilitates copper-catalyzed azide-alkyne cycloaddition reactions (CuAAc) with alkyne-containing molecules. Additionally, it can participate in strain-promoted alkyne-azide cycloaddition (SPAAC) with DBCO or BCN-modified compounds. This reagent is essential for enhancing the efficacy and specificity of targeted therapeutic agents in chemical biology research.

Bis-PEG9-NHS ester is a polyethylene glycol (PEG)-based linker designed for use in antibody-drug conjugates (ADCs) and PROTACs (proteolysis-targeting chimeras). This cleavable linker facilitates the attachment of drugs to antibodies, enhancing selective delivery and activity. Its application in PROTAC synthesis allows for targeted protein degradation, making it a valuable tool in drug discovery and development.

Gly-Gly-Phe-Gly-NH-CH2-O-CH2COOH is an ADC linker designed for the synthesis of drug-linker conjugates in antibody-drug conjugate (ADC) applications. This compound facilitates the construction of targeted therapeutics, enhancing the specificity and efficacy of drug delivery. It is particularly relevant in the development of complex conjugates such as Deruxtecan, providing researchers with a reliable tool for advancing ADC-based therapies.

Gly-Gly-Gly-PEG4-azide is an ADC linker primarily used in the synthesis of antibody-drug conjugates (ADCs). This compound features an azide functional group, enabling it to participate in copper-catalyzed azide-alkyne cycloaddition (CuAAc) reactions with alkyne-containing molecules. Additionally, it is capable of undergoing strain-promoted alkyne-azide cycloaddition (SPAAC) with bicyclo[6.1.0]nonyne (DBCO) or bicyclo[4.1.0]heptene (BCN) moieties, making it a versatile tool in chemical biology research and drug development applications.

N3-PEG3-CH2CH2COOH is a PEG-based PROTAC linker that facilitates selective protein degradation by enabling the synthesis of specific PROTACs, including BI-3663 and BI-4216. This compound contains an azide group, allowing it to engage in copper-catalyzed azide-alkyne cycloaddition (CuAAc) and strain-promoted alkyne-azide cycloaddition (SPAAC) reactions with alkyne, DBCO, or BCN-containing molecules. N3-PEG3-CH2CH2COOH is also applicable as a non-cleavable ADC linker in the development of antibody-drug conjugates, making it a versatile reagent for chemical biology research.

N-Boc-PEG1-bromide is a versatile cleavable linker targeting ADCs and PROTACs. This PEG/alkyl/ether-based reagent facilitates the synthesis of antibody-drug conjugates (ADCs) and enhances the design of proteolysis-targeting chimeras (PROTACs). Its unique properties allow for effective conjugation and release mechanisms, making it suitable for various applications in chemical biology and drug development research.

Propargyl-PEG1-NHS ester is a non-cleavable PEG linker designed for antibody-drug conjugation (ADC) applications. This reagent features an alkyne group that enables its use in copper-catalyzed azide-alkyne cycloaddition (CuAAc) reactions, facilitating efficient conjugation to azide-containing molecules. Its unique properties make it suitable for the synthesis of stable ADCs in research focused on targeted therapies and drug delivery systems.

DBCO-PEG24-NHS ester is a click chemistry reagent designed for selective conjugation through the reaction with primary amines, such as lysine side chains or aminosilane-coated surfaces, under neutral to slightly basic conditions. The NHS ester facilitates the formation of a stable covalent bond, while the hydrophilic PEG spacer enhances water solubility and offers a flexible linkage that reduces steric hindrance during ligation. This compound is particularly suited for applications in bioconjugation and the development of targeted delivery systems.

Fmoc-Val-Ala-PAB-PNP is a cleavable linker specifically designed for the synthesis of antibody-drug conjugates (ADCs). This compound facilitates the effective attachment and release of cytotoxic agents upon internalization, enhancing targeted delivery to tumor cells. It is invaluable for research in ADC development, enabling studies focused on improving therapeutic efficacy and reducing off-target effects.

Bis-PEG5-NHS ester is a polyethylene glycol (PEG) based linker that targets protein degradation for the development of PROTACs (proteolysis targeting chimeras) and serves as a cleavable linker in antibody-drug conjugates (ADCs). This compound facilitates the conjugation of bioactive molecules with antibodies, enhancing the targeted delivery of therapeutic agents. Its versatile application in synthesizing both PROTACs and ADCs makes it valuable for advancing research in targeted therapies and drug delivery systems.

Amino-PEG4-alcohol is a PEG-based linker designed for use in the synthesis of PROTACs (Proteolysis Targeting Chimeras). This linker facilitates the assembly of heterobifunctional molecules and enables targeted degradation of proteins within cellular systems. Additionally, Amino-PEG4-alcohol serves as a non-cleavable 4-unit PEG linker for the development of antibody-drug conjugates (ADCs), enhancing the delivery of therapeutic agents. It is suitable for applications in chemical biology and drug development research.

Methyl azetidine-3-carboxylate hydrochloride is a non-cleavable linker for antibody-drug conjugates (ADCs) that facilitates the stable attachment of cytotoxic agents to antibodies. This compound also serves as an alkyl chain-based linker in the development of PROTACs (proteolysis-targeting chimeras), enabling targeted protein degradation. Its robust chemical properties make it essential for advancing research in targeted therapeutics and drug delivery systems.

Boc-Val-Cit-PAB-PNP is a cleavable linker designed for the synthesis of antibody-drug conjugates (ADCs). This compound facilitates the selective release of therapeutic agents upon internalization, enhancing the efficacy of targeted cancer therapies. Its application extends to various research endeavors focused on developing and optimizing ADC formulations.

MAC glucuronide linker-1 is a cleavable linker specifically designed for antibody-drug conjugate (ADC) applications. It facilitates the targeted delivery of cytotoxic agents to cancer cells, enhancing therapeutic efficacy while minimizing off-target effects. This linker is suitable for various research applications, including the development and optimization of ADCs for cancer treatment.

DBCO-Sulfo-NHS ester sodium is an efficient ADC linker designed for the synthesis of antibody-drug conjugates (ADCs), facilitating targeted drug delivery. This reagent features a DBCO group that enables strain-promoted alkyne-azide cycloaddition (SPAAC) with azide-containing molecules. Its versatile coupling capabilities make it an essential tool for researchers developing novel therapeutics in cancer and other diseases.

Val-Cit-PAB-OSBT is a degradable ADC linker designed for antibody-drug conjugate applications. It consists of the polypeptide Val-Cit-PAB linked to OSBT moieties, enabling selective release of cytotoxic agents in targeted therapies. This compound facilitates precise drug delivery, enhancing the therapeutic index while minimizing off-target effects. Its applications include cancer research and the development of more effective targeted treatments.

Fmoc-NH-PEG8-CH2CH2COOH is a cleavable linker designed for antibody-drug conjugate (ADC) synthesis. This compound facilitates the conjugation of antibodies with therapeutic agents, enabling targeted drug delivery. Its unique structure supports efficient hydrolysis in the cellular environment, promoting the release of the drug at the site of action. Fmoc-NH-PEG8-CH2CH2COOH is essential for enhancing the efficacy and specificity of ADCs in cancer research and therapeutic development.

Boc-C16-COOH is a non-cleavable linker for the development of antibody-drug conjugates (ADCs), facilitating the stable attachment of cytotoxic agents to antibodies. Additionally, this alkyl chain-based compound serves as a versatile linker for the synthesis of PROTACs, enhancing targeted protein degradation applications. Its structural properties make it an essential component in advanced drug delivery and therapeutic strategies in chemical research.

Mal-PEG6-NHS ester is an ADC linker characterized by its Maleimide moiety, a six-unit polyethylene glycol (PEG) segment, and a N-hydroxysuccinimide (NHS) ester. This compound facilitates the conjugation of biomolecules by forming stable thioether bonds with cysteine residues, enhancing the delivery and efficacy of antibody-drug conjugates (ADCs). It is applicable in bioconjugation experiments and research aimed at developing targeted therapies.

N3-PEG3-C2-NHS ester is a non-cleavable linker designed for use in the synthesis of antibody-drug conjugates (ADCs), specifically facilitating the conjugation of biomolecules through versatile click chemistry approaches. This reagent features an azide group that enables copper-catalyzed azide-alkyne cycloaddition (CuAAc) with alkyne-containing compounds, as well as strain-promoted alkyne-azide cycloaddition (SPAAC) with DBCO or BCN groups. Its unique characteristics make it an essential component for developing stable and effective ADCs in therapeutic research.

Boc-NH-C6-Br is a non-cleavable linker specifically designed for use in antibody-drug conjugates (ADCs). It facilitates the stable attachment of therapeutic agents to antibodies, enhancing the efficacy and specificity of targeted cancer therapies. Its robust chemical properties make it suitable for various applications in ADC development and research, enabling effective delivery of cytotoxic drugs to cancer cells.

Boc-Val-Cit-OH is a cleavable linker specifically designed for the synthesis of antibody-drug conjugates (ADCs). This compound incorporates a valine-citrulline segment that allows for selective release of the attached drug in the target cells, enhancing therapeutic efficacy. Its application is pivotal in the development of ADCs that require controlled drug delivery mechanisms for targeted cancer therapy and other applications in drug discovery.

MC-Val-Ala-PAB-PNP is a cleavable linker designed for the synthesis of antibody-drug conjugates (ADCs). This reagent facilitates the selective release of the cytotoxic drug component upon internalization and cleavage by specific enzymes within target cells. Its application is crucial in the development of targeted cancer therapies, enhancing the specificity and efficacy of drug delivery.

Dap-NE hydrochloride is a dipeptide hydrochloride that functions as a cleavable antibody-drug conjugate (ADC) linker. This reagent facilitates the conjugation of antibodies to cytotoxic agents, enabling the development of ADCs for targeted cancer therapies. It is valuable in research focused on therapeutic delivery systems and the optimization of ADC efficacy.

Mal-Bal-Ph(β-D-Glucose)-7-MAD-MDCPT is a versatile ADC linker that facilitates the synthesis of antibody-drug conjugates (ADCs). This compound is designed to provide stable and efficient coupling between antibodies and cytotoxic agents, enhancing targeted delivery in cancer therapeutics. Its unique structure allows for precise modulation of drug release, thereby improving efficacy in research applications related to drug development and bioconjugation techniques.

NH2-PEG4-CH2CH2COOH is a cleavable four-unit polyethylene glycol (PEG) linker designed for the synthesis of antibody-drug conjugates (ADCs) and PROTACs (proteolysis-targeting chimeras). This linker facilitates the conjugation of antibodies with cytotoxic agents, enhancing targeted drug delivery and therapeutic efficacy. Additionally, its application in PROTAC synthesis supports the development of innovative strategies for targeted protein degradation.

Azido-PEG7-amine is a non-cleavable 7-unit polyethylene glycol (PEG) linker designed for use in the synthesis of antibody-drug conjugates (ADCs) and PROTACs (Proteolysis Targeting Chimeras). This versatile linker features an azide functional group, enabling it to participate in copper-catalyzed azide-alkyne cycloaddition (CuAAc) reactions with alkyne-containing molecules. Additionally, it can engage in strain-promoted alkyne-azide cycloaddition (SPAAC) with molecules containing DBCO or BCN groups. Azido-PEG7-amine serves as an important tool for the development of advanced bioconjugates in chemical research.

Boc-NH-PEG4-CH2CH2COOH is a PEG-based linker designed for use in the synthesis of PROTACs (Proteolysis Targeting Chimeras), facilitating targeted degradation of specific proteins. Additionally, this compound serves as a cleavable linker for antibody-drug conjugates (ADCs), enhancing the delivery of therapeutic agents to specific cellular targets. Its versatile applications make it a valuable tool in chemical biology and drug development research.

DTSSP Crosslinker is a cleavable agent designed specifically for use in the synthesis of antibody-drug conjugates (ADCs). By forming stable covalent bonds between antibodies and cytotoxic drugs, it facilitates targeted delivery and enhances therapeutic efficacy. This linker is essential for research applications involving ADC development and optimization.

N-Boc-PEG4-bromide is a PEG-based linker that functions as a cleavable agent in antibody-drug conjugates (ADCs) and PROTACs. This compound facilitates the synthesis of PROTACs by providing a flexible and hydrophilic connector, enhancing solubility and biological activity. Its functional bromide group allows for effective conjugation to various biomolecules, making it a valuable tool in drug development research.

Mal-PEG3-NHS ester is a non-cleavable antibody-drug conjugate (ADC) linker that features a maleimide group for efficient covalent attachment to thiol-containing molecules. This compound facilitates the development of ADCs by enabling stable conjugation between antibodies and cytotoxic agents, enhancing targeted delivery in therapeutic applications. Mal-PEG3-NHS ester is particularly valuable in cancer research, as it supports the design of effective therapies that minimize off-target effects while maximizing tumor cell specificity.

Gly-Gly-Gly-PEG2-azide is an ADC linker that facilitates the synthesis of antibody-drug conjugates (ADCs). This reagent features an azide group, enabling it to participate in copper-catalyzed azide-alkyne cycloaddition (CuAAc) with alkyne-containing molecules. Additionally, it can undergo strain-promoted alkyne-azide cycloaddition (SPAAC) with DBCO or BCN-functionalized entities, making it a versatile tool for bioconjugation applications in chemical biology and therapeutic development.

Fluorescein-DBCO is a non-cleavable linker designed for use in the formation of antibody-drug conjugates (ADCs). This compound features a dibenzocyclooctyne (DBCO) group, enabling it to participate in strain-promoted alkyne-azide cycloaddition (SPAAC) reactions with azide-containing molecules. Its unique properties make Fluorescein-DBCO an essential tool for researchers focusing on targeted drug delivery and cancer therapy applications through ADC development.